Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:44 am Sale | 2025-03-31 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 53,834,873 4.300% | -29,863,342 (-35.68%) | Filing History |
| 2025-04-24 09:27 am Sale | 2025-03-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 101,739,273 8.200% | -21,051,024 (-17.14%) | Filing History |
| 2025-03-20 4:32 pm Purchase | 2025-03-18 | 13G | Kalaris Therapeutics Inc KLRS | GILEAD SCIENCES INC. GILD | 723,273 3.900% | 723,273 (New Position) | Filing History |
| 2025-03-05 5:00 pm Unchanged | 2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 39,691,649 35.000% | 0 (Unchanged) | Filing History |
| 2025-02-20 7:43 pm Purchase | 2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 39,691,649 35.000% | 8,158,868 (+25.87%) | Filing History |
| 2025-02-13 4:22 pm Sale | 2024-12-31 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 1,521,312 3.600% | -1,410,155 (-48.10%) | Filing History |
| 2025-01-10 3:46 pm Unchanged | 2025-01-07 | 13D | Galapagos NV GLPG | GILEAD SCIENCES INC. GILD | 20,981,010 29.900% | 0 (Unchanged) | Filing History |
| 2024-12-23 8:17 pm Purchase | 2024-12-19 | 13D | Assembly Biosciences, Inc. ASMB | GILEAD SCIENCES INC. GILD | 2,209,471 29.900% | 940,499 (+74.12%) | Filing History |
| 2024-12-19 4:15 pm Purchase | 2024-12-18 | 13G | Xilio Therapeutics, Inc. XLO | GILEAD SCIENCES INC. GILD | 9,105,451 19.900% | 1,759,978 (+23.96%) | Filing History |
| 2024-06-20 8:35 pm Purchase | 2024-06-17 | 13D | Assembly Biosciences, Inc. ASMB | GILEAD SCIENCES INC. GILD | 1,268,972 19.990% | 179,500 (+16.48%) | Filing History |
| 2024-05-02 9:29 pm Purchase | 2024-04-30 | 13D | Galapagos NV GLPG | GILEAD SCIENCES INC. GILD | 20,981,010 29.900% | 352,081 (+1.71%) | Filing History |
| 2024-04-19 4:31 pm Purchase | 2024-04-10 | 13G | Leap Therapeutics, Inc. LPTX | GILEAD SCIENCES INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | Filing History |
| 2024-04-05 4:31 pm Purchase | 2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO | GILEAD SCIENCES INC. GILD | 7,345,473 19.900% | 7,345,473 (New Position) | Filing History |
| 2024-02-20 4:31 pm Purchase | 2024-02-12 | 13G | Kyverna Therapeutics, Inc. KYTX | GILEAD SCIENCES INC. GILD | 4,126,119 9.600% | 4,126,119 (New Position) | Filing History |
| 2024-02-13 5:06 pm Sale | 2023-12-29 | 13G | Gilead Sciences, Inc. GILD | The Vanguard Group | 111,820,711 8.970% | -217,613 (-0.19%) | Filing History |
| 2024-02-13 4:54 pm Purchase | 2023-12-31 | 13G | AlloVir, Inc. ALVR | GILEAD SCIENCES INC. GILD | 723,273 14.600% | 127,429 (+21.39%) | Filing History |
| 2024-02-13 4:51 pm Unchanged | 2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 4.800% | 0 (Unchanged) | Filing History |
| 2024-02-09 6:21 pm Purchase | 2024-02-07 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 83,698,215 6.700% | 14,797,217 (+21.48%) | Filing History |
| 2024-01-31 4:58 pm Purchase | 2024-01-29 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 31,532,781 35.000% | 5,945,828 (+23.24%) | Filing History |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 122,790,297 9.900% | -8,765,472 (-6.66%) | Filing History |